Stay updated on Melflufen-Dex vs Pom-Dex in Len Refrac RRMM Clinical Trial
Sign up to get notified when there's something new on the Melflufen-Dex vs Pom-Dex in Len Refrac RRMM Clinical Trial page.

Latest updates to the Melflufen-Dex vs Pom-Dex in Len Refrac RRMM Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page header, indicating a minor update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe page history now shows Revision: v3.3.3 replacing v3.3.2, and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.1%

- Check59 days agoChange DetectedThe history page shows a minor revision update: Revision: v3.3.2 was added and Revision: v3.2.0 was removed. No study details, statuses, or results are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check66 days agoChange DetectedDeleted the site-wide government funding notice about operating status; study history and navigation remain unchanged.SummaryDifference0.3%

- Check88 days agoChange DetectedThe new screenshot shows only minor UI/layout adjustments on the Record History page and an additional version entry; no substantive study-data changes (status, arms, eligibility) are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check109 days agoChange DetectedSignificant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 reference removed.SummaryDifference8%

Stay in the know with updates to Melflufen-Dex vs Pom-Dex in Len Refrac RRMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Melflufen-Dex vs Pom-Dex in Len Refrac RRMM Clinical Trial page.